This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignee: Ucb Pharma, S.a.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Roland Burli: Innovator in Medicine
Introduction: Roland Burli is a male inventor based in Saffron Walden, Great Britain, known for his groundbreaking work in the field of medicine. With a keen focus on developing novel treatments for a variety of medical conditions, Burli has made significant contributions to the pharmaceutical industry.
Latest Patents: Roland Burli holds one patent for his invention titled "Fused pyridine and pyrazine derivatives as kinase inhibitors." This patent describes a series of amino-substituted fused pyridine and pyrazine derivatives, particularly amino-substituted quinoline and quinoxaline derivatives, that act as selective inhibitors of PI3 kinase enzymes. These compounds have shown promise in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive, and ophthalmic conditions.
Career Highlights: Burli is currently affiliated with UCB Pharma S.A., a leading pharmaceutical company. His work at UCB Pharma has been instrumental in advancing the development of innovative medications for various diseases. Burli's expertise in medicinal chemistry and drug discovery has paved the way for the creation of potentially life-changing therapies.
Collaborations: In his professional journey, Roland Burli has collaborated with esteemed colleagues such as Daniel Rees Allen and Julien Alistair Brown. Together, they have worked on cutting-edge research projects aimed at revolutionizing the pharmaceutical landscape and improving patient care.
Conclusion: Roland Burli's inventive spirit and dedication to improving healthcare have positioned him as a key figure in the field of medicine. His patent on fused pyridine and pyrazine derivatives underscores his commitment to finding new and effective treatments for a wide range of medical conditions. With a proven track record of innovation, Burli continues to drive progress in the pharmaceutical industry, offering hope for a healthier future.